Research Article

Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi

Volume: 11 Number: 3 September 30, 2024
EN TR

Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi

Abstract

Objective: In this study, we aimed to examine the effect of fear of Covid-19 on immunosuppressive treatment compliance in patients who underwent liver transplantation surgery. Method: This descriptive study was conducted at the liver transplant center of a university hospital with the participation of 169 patients. Data; It was collected face to face and online by researchers between February and March 2024. Data were collected using the Personal Information Form, Coronavirus (Covid-19) Fear Scale and Compliance with Immunosuppressive Medication Use scales. Data analysis was done with IBM SPSS (Statistical Package for the Social Sciences) Statistics 25 program. Results: 58.6% of the patients were male, 80.5% were married, 72% of the patients used tacrolimus as the immunosuppressive drug after the transplant, 63.3% did not catch Covid-19, 15.4% were diagnosed with Covid-19. It was determined that he lost a relative. Simple linear regression analysis was performed to determine the relationship between the scales used and no statistically significant relationship was found between the two scales (p>0.05). Conclusion: It is recommended to create support programs that will include the normalization processes of liver transplant patients who are afraid of Covid-19 in order to become more compatible with their daily lives.

Keywords

References

  1. 1. World Health Organization, (2021). "Adolescent and Young Adult Health". Erişim adresi: https://www.who.int/news-room/fact-sheets/detail/adolescents-health-risks-and-solutions.
  2. 2. Akgün, Ş., TOK, H. H., & OZTAŞ, D. (2021). Hemşirelik öğrencilerinin sağlıklı yaşam biçimi davranışları ve sağlık okuryazarlık düzeyleri. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 10(2), 247-256.
  3. 3. Committee on Improving the Health, Safety, and Well-Being of Young Adults; Board on Children, Youth, and Families; Institute of Medicine; National Research Council; Bonnie, R.J, Stroud, C. And Breiner, H. (2015). "Investing in the Health and Well-Being of Young Adults", Washington (DC): National Academies Press (US); 2015 Jan 27. Summary. Erişim adresi: https://www.ncbi.nlm.nih.gov/books/NBK284776.
  4. 4. World Health Organization. (2021). "Good Health in Youth Sets The Stage for Well-Being in Later Life. 2010." Erişim adresi: https://www.who.int/mediacentre/multimedia/podcasts/2010/year_of_youth_20100812/en.
  5. 5. Hagströmer, M., Oja, P., & Sjöström, M. (2006). The International Physical Activity Questionnaire (UFAA): a study of concurrent and construct validity. Public health nutrition, 9(6), 755-762.
  6. 6. Saglam M, Arikan H, Savci S, et al. International physical activity questionnaire: Reliability and validity of the Turkish version. Percept Mot Skills. 2010;111(1):278-284.
  7. 7. Okyay P, Abacıgil F, Harlak H. Türkiye Sağlık Okuryazarlığı Ölçeği-32 (TSOY-32).Türkiye Sağlık Okuryazarlığı Ölçekleri Güvenilirlik ve Geçerlilik Çalışması. TC Sağlık Bakanlığı 2016:43-61
  8. 8. Walker, S. N., & Hill-Polerecky, D. M. (1996). Psychometric evaluation of the health-promoting lifestyle profile II. Unpublished manuscript, University of Nebraska Medical Center, 13, 120-6.

Details

Primary Language

English

Subjects

Surgery (Other)

Journal Section

Research Article

Publication Date

September 30, 2024

Submission Date

April 19, 2024

Acceptance Date

August 11, 2024

Published in Issue

Year 2024 Volume: 11 Number: 3

APA
Güneş, H., Kavak, M., & Beyoğlu, S. (2024). Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal, 11(3), 401-408. https://doi.org/10.34087/cbusbed.1470879
AMA
1.Güneş H, Kavak M, Beyoğlu S. Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal. 2024;11(3):401-408. doi:10.34087/cbusbed.1470879
Chicago
Güneş, Hüseyin, Mustafa Kavak, and Sakine Beyoğlu. 2024. “Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi”. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal 11 (3): 401-8. https://doi.org/10.34087/cbusbed.1470879.
EndNote
Güneş H, Kavak M, Beyoğlu S (September 1, 2024) Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal 11 3 401–408.
IEEE
[1]H. Güneş, M. Kavak, and S. Beyoğlu, “Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi”, CBU-SBED: Celal Bayar University-Health Sciences Institute Journal, vol. 11, no. 3, pp. 401–408, Sept. 2024, doi: 10.34087/cbusbed.1470879.
ISNAD
Güneş, Hüseyin - Kavak, Mustafa - Beyoğlu, Sakine. “Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi”. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal 11/3 (September 1, 2024): 401-408. https://doi.org/10.34087/cbusbed.1470879.
JAMA
1.Güneş H, Kavak M, Beyoğlu S. Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal. 2024;11:401–408.
MLA
Güneş, Hüseyin, et al. “Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi”. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal, vol. 11, no. 3, Sept. 2024, pp. 401-8, doi:10.34087/cbusbed.1470879.
Vancouver
1.Hüseyin Güneş, Mustafa Kavak, Sakine Beyoğlu. Karaciğer Transplantasyonu Olan Hastalarda Covid-19 Korkusunun İmmünosüpresif Tedavi Uyumuna Etkisi. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal. 2024 Sep. 1;11(3):401-8. doi:10.34087/cbusbed.1470879

Cited By